Cargando…

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer

BACKGROUND: The therapeutic effect of chemotherapy is still unclear for clinical usage among second primary non‐small cell lung cancer (NSCLC) patients. The aim of this study was to verify the therapeutic effect of chemotherapy and identify the prognostic factors among patients who had received chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhile, Wu, Yijun, Wang, Li, Gong, Liang, Han, Chang, Xie, Fucun, Li, Shanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882385/ https://www.ncbi.nlm.nih.gov/pubmed/33295696 http://dx.doi.org/10.1111/1759-7714.13762

Ejemplares similares

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms
por: Wu, Yijun, et al.
Publicado: (2020)

Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer
por: Han, Chang, et al.
Publicado: (2021)

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
por: Wu, Yijun, et al.
Publicado: (2023)

Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses
por: Wu, Yijun, et al.
Publicado: (2023)

External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
por: Huang, Guanghua, et al.
Publicado: (2022)

Prognostic outcome after second primary lung cancer in patients with previously treated lung cancer by radiotherapy
por: Wu, Yijun, et al.
Publicado: (2020)

Clinicopathological models for predicting lymph node metastasis in patients with early-stage lung adenocarcinoma: the application of machine learning algorithms
por: Chong, Yuming, et al.
Publicado: (2021)

Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
por: Bai, Wenliang, et al.
Publicado: (2021)

Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution
por: Lee, Seok Jeong, et al.
Publicado: (2014)

The analysis of prognosis factor in patients with non-small cell lung cancer receiving pneumonectomy
por: Wang, Guige, et al.
Publicado: (2020)

Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared with Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer
por: Li, Ning, et al.
Publicado: (2014)

A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients
por: Mo, Hongnan, et al.
Publicado: (2016)

Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?
por: Liu, Yutao, et al.
Publicado: (2017)

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients
por: Rothschild, S.I., et al.
Publicado: (2021)

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer
por: Choi, Eunji, et al.
Publicado: (2021)

Characteristics of nosocomial infection and its effects on the survival of chemotherapy patients with advanced non-small cell lung cancer
por: Wang, Lili, et al.
Publicado: (2017)

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)

Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
por: Hirata, Tsuyoshi, et al.
Publicado: (2023)

The clinical-histologic and prognostic characteristics in patients with a second primary non-small-cell lung cancer after a lobectomy
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
por: Li, Kaidi, et al.
Publicado: (2017)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
por: Wang, Hai-ying, et al.
Publicado: (2020)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy
por: Zeng, Yuan, et al.
Publicado: (2021)

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer
por: Chen, Dongna, et al.
Publicado: (2023)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
por: Tu, Zegui, et al.
Publicado: (2021)

Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer
por: Nakamura, Masatoshi, et al.
Publicado: (2023)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022)

Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease
por: Otsuka, Kenji, et al.
Publicado: (2022)

Northampton outcome for first and second line chemotherapy in non-small cell lung cancer: 5 years data
por: Eldeeb, Hany, et al.
Publicado: (2012)

Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer
por: Zhang, Fan, et al.
Publicado: (2020)

Incidence, mortality, and survival analyses of patients with thymic lymphoma
por: Wang, Li, et al.
Publicado: (2022)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer
por: Aldarouish, Mohanad, et al.
Publicado: (2019)

PD‐1/PD‐L1 co‐location: A novel biomarker for immunotherapy response in non‐small cell lung cancer
por: Diao, Xiayao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pag8s6ms0dc31kgffri9u2flp9